InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Cover Story

  • Focus on biotechnology

  • Of mice and men

    The Harvard oncomouse drew world attention to the issue of patentability of life forms. Pierre-André Dubois and Kate McCallie explore the divergent approaches of patent authorities in the US, Canada and the EU

  • What nanotechnology means for IP

    As the race among global leaders spurs exponential growth in nanotechnology, companies must keep watch on intellectual property issues emerging with the new field, explains Vicki Norton

  • The business of biotech

    Survival and success for biotech companies across the US and worldwide is a tenuous and arduous endeavor in today's economy. Robin Silva offers some tips on how to ride the wave successfully

  • Expanding exemptions for generics

    The Hatch-Waxman Act in the US represented a careful balance of interests between the generic and brand name pharmaceutical manufacturers. William Feiler and Paula Wittmayer examine the Safe Harbor exemption and the challenges it represents to the biotech industry

  • Building up biotech in Ukraine

    Rapid innovation and intense investment in the biotech industry has required patent protection to adjust accordingly. Antonina Pakharenko-Anderson explains how Ukraine is rising to the biotech challenge

Features

  • News focus: The clash over canola

    A local farmer's appeal to Canada's Supreme Court in a case involving agribusiness leader Monsanto could set the limits of patent holders' rights. Sam Mamudi examines the dispute

  • Case study: Providing premium protection

    Bruce Proctor has global responsibility for all IP matters at premium drinks company Diageo. He tells Ingrid Hering about the challenges of protecting a brand portfolio that includes Smirnoff, Baileys and Guinness

  • Insight: Maintaining the anti-counterfeiting momentum

    Improved trade mark legislation and a concentrated effort from rights owners are achieving results against counterfeiting in China. The hope is now the Chinese leadership will take a direct role in the campaign, reports Ralph Cunningham

  • View from the bench

    Interview: Judge Arjen Meij, Court of First Instance With an increasing number of Community Trade Mark cases reaching the European courts, Stéphanie Bodoni asks judge Arjen Meij from the European Court of First Instance how well the system is coping

  • Trade marking country code domains

    The registrability of ccTLDs as trade marks burst into the open in Singapore late last year. Though the applications were withdrawn, some legal issues remain outstanding, explains Bryan Tan

  • A dusty road to standards licensing

    The GSM story is one of success for the market as well as investors in the technology and IP rights holders, and it will be for the market to resolve the forthcoming issues on 3G IP rights by tried and tested methods, argues Hugh Dunlop

  • INTA

    Snapshots of INTA's 125th Annual Meeting in Amsterdam

  • Letter from the editor...

  • The perfect biotech match

    Marion Rees, IP manager, Virax, Australia

Country Updates

More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements